FOSUN HEALTH Logo

Bone & Soft Tissue Tumors Causes

catalogue

Bone & Soft Tissue Tumors Causes

Bone & Soft Tissue Tumors Causes

The honest starting point is that in most people who develop a bone or soft tissue tumor, no cause is ever identified, and nothing they did or did not do explains it. What is known falls into a small number of categories: an inherited predisposition in a minority of patients, previous radiotherapy to the area many years earlier, long-standing swelling of a limb in one specific type, and a small number of occupational exposures. Everything else that is commonly blamed — an injury, a diet, stress, a previous X-ray — is not supported by the evidence.

What is actually established about the origin of these tumors

A sarcoma begins when the cells of a tissue accumulate changes in the genes that control how they grow and divide. Some of those changes are acquired during life and some are inherited; in most patients no single external cause is ever identified, and the changes appear to be the result of ordinary errors in cell division accumulating over time. That is an unsatisfying answer, and it is the accurate one, and it matters because the alternative — searching for something to blame — rarely produces anything and often produces guilt.

It is worth separating two words that get used interchangeably. A risk factor is something that raises the likelihood of a disease across a group of people; it does not mean that it caused the disease in any one person, and the great majority of people with that risk factor never develop a sarcoma. A cause is something whose removal would prevent the disease. By that standard, very few causes are known in this family of tumors, and most of what is written about them is a list of associations.

Where a cause genuinely is identifiable, it is usually recognisable from the history: a patient who was treated with radiotherapy to that area years earlier, or one with a known inherited syndrome, or one whose tumor type is defined by a specific genetic change that runs in the family. Those situations are the minority, and they are the reason a family history and a treatment history are taken at the first appointment rather than treated as background detail.

Age, type and what the pattern does and does not mean

Different tumors in this family occur at different stages of life, and the pattern is distinctive enough that it contributes to the diagnosis. The bone-forming sarcoma and the small round cell tumor of bone are seen mainly in children, adolescents and young adults, and they cluster around the periods of fastest skeletal growth. Cartilage-forming tumors and most soft tissue sarcomas of adults appear later, and the fatty and undifferentiated tumors are more typical of middle and later life. Some types, such as the tumor that arises in the wall of the gut, span a wide age range.

This pattern describes when tumors are likely to appear; it does not explain why. Age is not a cause in the ordinary sense, and it is worth being careful about the inference, because it can mislead in both directions: a young person with a lump is not automatically safe, and an older person with a new bone pain is not automatically looking at a sarcoma. Both situations are decided by imaging and tissue rather than by age.

The practical value of the age pattern lies elsewhere: it is one of the pieces of information that helps a clinician decide how urgently to investigate. A lump in an adolescent that is enlarging, or night pain in a long bone in a young adult, moves up the list for imaging because the commonest tumors of that age group are the ones with the most to lose from a delay.

Inherited syndromes: a minority of cases, with specific implications

A small proportion of sarcomas occur in people who carry an inherited change that raises the risk across their lifetime. These syndromes are uncommon individually, and together they account for only a minority of all cases — but they matter, because recognising one changes the surveillance offered to the patient and to their family.

ConditionWhat is inheritedWhy it is recognised
Li-Fraumeni syndromeA change in the TP53 geneA pattern of cancers at young ages in a family, including sarcomas, and a need for surveillance across several organs
Hereditary retinoblastomaA change in the RB1 geneA childhood eye tumour, followed years later by a raised risk of a bone sarcoma, particularly after radiotherapy
Neurofibromatosis type 1A change in the NF1 geneCharacteristic skin findings and nerve tumours, with a small risk that one of them becomes malignant
Multiple cartilage tumoursOllier disease and Maffucci syndrome, usually not inherited from a parentMany cartilage islands or growths in the bones, one of which may change over time

Two points follow. The first is that a personal or family history of these conditions is worth stating at the first appointment rather than assuming it is not relevant; it affects how the tumor is assessed and what surveillance is arranged afterwards. The second is that most people who develop a sarcoma have none of these conditions, and no family history at all. The presence of an inherited syndrome is an explanation, not the rule.

Previous radiotherapy, and the long interval before it matters

Radiotherapy given to treat an earlier cancer is one of the clearest established risk factors for a sarcoma, and it is a risk that takes years to appear. Tumors arising in a previously irradiated area usually do so many years after the treatment, and the interval is long enough that the original cancer is often a distant memory. This is why a sarcoma appearing in a previously treated area is specifically asked about rather than treated as a coincidence.

It is important to keep this in proportion. Radiotherapy remains a treatment that cures or controls many cancers, and the great majority of patients treated with it never develop a second tumour in that area. The risk is real and it is small, and no patient should decline radiotherapy that is needed on the basis of this page. Where radiotherapy has been given previously, however, it does affect the planning of any later operation in that area, because the tissue has been changed and heals less reliably.

Diagnostic X-rays are a different matter and are not a comparable risk. The doses involved in imaging are orders of magnitude smaller than those in treatment, and while the general principle of not irradiating without a reason applies to everyone, a previous radiograph or CT scan is not a plausible explanation for a sarcoma.

Long-standing swelling of a limb

Chronic lymphoedema — persistent swelling of an arm or a leg, most often after treatment for another cancer or as a result of a congenital condition — is associated with one particular type of soft tissue sarcoma that arises in the lymphatic channels. The tumor is uncommon, and the association is with swelling that has been present for a long time rather than with swelling that has just appeared.

The practical implication is not that lymphoedema is dangerous; it is that a limb with long-standing swelling deserves the same attention to change as any other. A new lump, a change in the character of the swelling, or pain in an area that has been swollen for years is a reason to be assessed rather than assumed to be part of the original problem.

For patients who have had lymph nodes removed or irradiated, this is one more reason that surveillance and prompt reporting of change matter. It is not a reason for alarm, and the association is far rarer than the swelling itself.

Occupational and chemical exposures

A small number of chemical and occupational exposures are established as causes of specific sarcomas, and they are rare rather than common. Vinyl chloride, used in the manufacture of certain plastics, is linked to a sarcoma of the liver; some chlorinated solvents and dioxins have been associated with soft tissue sarcomas in occupational studies; and higher-dose ionising radiation in the workplace, historically, contributed to bone sarcomas in occupations such as luminous dial painting. A very small number of sarcomas have also been linked to implanted materials, and the medical devices concerned are well characterised rather than general.

What these exposures have in common is that they are identifiable from an occupational history, and that they account for a very small share of cases. They are worth mentioning at the first appointment if the patient has worked in the chemical, plastics or nuclear industries, or with radiation, but they are not a reason for most people to look for an exposure in their past — in the great majority of cases there is none to find.

It is also worth noting the pattern these exposures follow: they are specific to particular tumor types rather than to sarcoma as a whole. That is consistent with what is understood about the disease — a sarcoma is defined by the tissue and by the genetic change that drove it, and different causes lead to different tumors.

What does not cause these tumors

Several things are commonly assumed to be causes and are not. Going through them is not a courtesy; it prevents people from spending the months after a diagnosis searching their own history for something to blame, and it prevents a genuinely informative symptom from being dismissed as "just the old injury".

  • An injury. This is the most persistent misunderstanding in the whole family of diseases. A sarcoma is frequently noticed after a knock, a fall or a sports injury, and the reason is that the injury draws attention to an area that was already abnormal. There is no evidence that trauma causes a sarcoma, and the sequence is the reverse of what it looks like.
  • Diet, weight and lifestyle. Unlike many common cancers, sarcomas are not established as being caused by diet, body weight, alcohol or physical inactivity. This is worth stating plainly because the reflex to look for a lifestyle explanation is strong, and here it leads nowhere.
  • Stress and emotional events. There is no established mechanism by which psychological stress causes a sarcoma, and the search for one retrospectively tends to be harmful rather than useful.
  • Smoking. Smoking is a cause of many cancers and is not established as a cause of sarcoma. This is not an argument for smoking; it is an argument against attributing a sarcoma to it.
  • A previous diagnostic X-ray or CT scan. The doses used in imaging are far too small, and the attribution is not supported.
  • Infection. Sarcomas are not infectious and are not transmitted between people.

Common beliefs, and what the evidence says

Common beliefWhat is known
"The knock caused it."The tumor was almost always there first; the injury revealed it. Trauma is not an established cause
"If it hurts, it is serious; if it does not, it is not."Pain bears little relation to the diagnosis. Many sarcomas are painless at first, and most painful lumps are benign
"A benign result on the scan means it can be ignored."Imaging can be reassuring without being conclusive, and the diagnosis is made from tissue. A lump that continues to change should be reassessed
"It runs in families, so nothing can be done."Most cases are not inherited, and where an inherited syndrome is present, surveillance and early assessment are the response
"A sarcoma spreads only to the bone."The lungs are the usual site; bone imaging is used for the types that tend to reach other bones
"Waiting a few weeks will not matter."For most lumps it will not. For a sarcoma, prompt referral and a properly planned biopsy matter a great deal

Frequently Asked Questions

I injured my leg a month ago and there is a lump. Did the injury cause it?

Almost certainly not, and the direction of cause is the opposite of what it feels like. A sarcoma is often first noticed after a knock, a fall or a sporting injury because the injury makes the area sore or calls attention to a swelling that was already there. No study has established trauma as a cause of bone or soft tissue sarcoma. The importance of getting this the right way round is practical rather than philosophical: when pain and a lump are attributed to an injury, they are often watched for weeks or months before being imaged, and that delay is the one thing in this disease that is genuinely avoidable.

Does a family history mean my children will develop this?

Usually not. Most bone and soft tissue tumors occur without any inherited component, and a sarcoma in one family member does not by itself indicate a syndrome. A genetic cause is worth investigating when there are specific features: several cancers of particular types at young ages in the same family, a known syndrome such as Li-Fraumeni or neurofibromatosis type 1, a childhood eye tumor, or a sarcoma in someone who also had an unusual second cancer. If any of those apply, genetic assessment is offered, and where a syndrome is confirmed, surveillance is arranged for relatives who carry it. Where they do not apply, the response is reassurance rather than testing.

Can a sarcoma be caused by something I was exposed to at work?

It can, in a very small number of situations, and these are specific rather than general. The clearest examples involve high-level exposure to vinyl chloride in plastics manufacture, associated with a sarcoma of the liver; some chlorinated solvents and dioxins, associated with soft tissue sarcomas in occupational studies; and historically, work with radium and other radioactive materials. Each of these is linked to particular tumor types and particular industries, and each is rare. If you have worked in chemical manufacturing, the plastics industry or with radiation sources, mention it — but for most people there is no occupational exposure to find, and the absence of one is not a gap in the history.

Is it true that these tumors are more common after other cancer treatment?

It is true that radiotherapy given to treat an earlier cancer raises the risk of a sarcoma arising in the treated area many years later, and that this is one of the clearest established risk factors in this family of tumors. It is also true that the risk is small: the great majority of patients treated with radiotherapy never develop a second tumor in that area, and radiotherapy continues to cure or control many cancers. The practical consequences are two. If you have had radiotherapy in the past, tell the team assessing a new lump in that area, because it changes the assessment. And if you are offered radiotherapy now, this risk is not a reason to decline treatment that is needed — it is a reason to have surveillance arranged afterwards.

Send the history and the images, get a written view

Upload the MRI and radiograph images with their reports and dates, the biopsy and pathology report in full, the operative notes if an operation has taken place, and a short summary of any previous radiotherapy, any known inherited condition, and any relevant occupational exposure. Our sarcoma team will return a written opinion within about 48 hours of the file being complete, setting out what the imaging shows and what the next step should be.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

WhatsApp +86 172-7459-8280 · EN / 中文 · 24h within business hours

Follow Fosun Health

Apply for an Appointment

Do you have test results*